Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis
Kelly R. Cotchett, Bonnie N. Dittel, Ahmed Z. Obeidat
Topics & Concepts
OcrelizumabOfatumumabMedicineTeriflunomideClinical trialMultiple sclerosisAdverse effectPhases of clinical researchCD20PharmacologyFingolimodRituximabInternal medicineImmunologyLymphomaMultiple Sclerosis Research StudiesMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses